Baldness can teach us something about blogging? You might be surprised! My mission with this blog is to responsibly use its influence for good for educational outreach to help people learn about stem cells. Can this blog make a difference? Does it have any influence? It seems so. Blogging is a lot more powerful than […]
Baldness points to big positive power of blogs Read More »
When a high-profile paper ends up having mistakes, it can be a big deal and cause a lot of problems for the authors and the field. Recently, a sexy Cell paper on ES cell cloning from the lab of Shoukhrat Mitalipov was published and soon a number of mistakes were identified. How does that impact
What do you make of the human cloning paper mistakes? Take our poll Read More »
As many of you know, the Coalition for the Advancement of Medical Research (CAMR) announced today that it will dissolve as an organization. I both emailed and talked on the phone with the President of CAMR, Amy Rick (who by the way is also CEO of the Parkinson’s Action Network (PAN)). Below is a concise
Interview with CAMR President & PAN CEO, Amy Comstock Rick Read More »
Today’s post is an interview I did with Dr. Van Bokkelen covering 10 questions. Dr. Gil Van Bokkelen is Chairman and CEO of Athersys, Inc., a company that has focused heavily on stem cells and regenerative medicine for more than a decade. For more on Dr. Van Bokkelen’s background see additional bio section at the end of
Interview with Gil Van Bokkelen of Athersys Read More »
One of the great areas of confusion over the human cloning development this week is whether human cloning is legal or illegal. With few exceptions, human cloning in general is legal in the US. Update: in 2020 it still appears that reproductive human cloning is legal in the US. It just hasn’t gotten that much
Deja you: human cloning generally legal in the US Read More »
Advanced Cell Technology (ACT) has confirmed that one of the patient in a clinical trial that it is running for treatment of macular degeneration, the leading cause of blindness worldwide, has shown a striking improvement in vision. The patient reportedly had 20/400 vision prior to treatment and now has 20/40 vision after treatment. ACT uses an
Striking improvement in vision in one ACT trial participant Read More »
I recently did a poll (still running here) about a hypothetical stem cell hotshot called Dr. Famous who might have published a recent paper that was sexy, but crappy. This situation sure rang a bell with a lot of people! In fact, a half dozen people contacted me directly (and privately) to talk about it
Go ahead & blog about Dr. Famous’ sexy, but crappy paper, most people say Read More »
To blog or not to blog? Sometimes that is the question and a tough one. Keep going or shut it down? Let’s say that you are a blogger and scientist. I am one of those people wearing both of those hats. A sexy paper comes out in your field. It’s all over the Internet and
To blog or not to blog about sexy, but crappy paper from Dr. Famous? Read More »
UPDATE: Unfortunately the Betatrophin paper discussed here originally back in 2013 has now largely been proven to have come to incorrect conclusions (for more read this). Today Harvard Stem Cell Institute (HSCI) reported the discovery, in a paper in Cell by Harvard Professor Doug Melton, of a powerful new hormone called Betatrophin that can stimulate
Doug Melton Betatrophin Discovery Points to Future Diabetes Treatment? Read More »
Harvard Stem Cell Institute (HSCI) is making a big announcement today about stems, the biggest they say in their almost decade-long existence. Last night I speculated/predicted some possible announcements. Today I’m betting they will announce the discovery of a novel factor called Betatrophin. More on Betatrophin in a minute, but first why do I think
What is Betatrophin & why is Harvard so excited about it? Read More »